Related Experiment Videos
Intraaortic balloon pumping assist following open heart surgery for coronary artery disease
Insights
Intraaortic balloon pump (IABP) support aids patients after coronary artery surgery. This temporary mechanical circulatory support significantly improves survival rates for critically ill patients.
Area of Science:
- Cardiovascular Surgery
- Mechanical Circulatory Support
- Cardiac Surgery
Background:
- Coronary artery disease often necessitates surgical intervention.
- Cardiogenic shock and difficulties weaning from cardiopulmonary bypass are critical complications.
- Intra-aortic balloon pump (IABP) is a temporary mechanical circulatory support device.
Purpose of the Study:
- To evaluate the effectiveness of Intra-aortic balloon pump (IABP) assist in patients undergoing coronary artery surgery.
- To assess the impact of IABP on survival rates in patients with severe left ventricular dysfunction or cardiogenic shock.
Main Methods:
- Retrospective analysis of 36 patients who received IABP assist.
- IABP use was categorized based on timing (preoperative, intraoperative weaning failure, postoperative shock).
- Patient outcomes, including survival rates and ejection fraction, were analyzed.
Main Results:
- IABP assist was required in 31 patients to terminate cardiopulmonary bypass.
- Three patients received IABP preoperatively due to cardiogenic shock from myocardial infarction.
- Overall survival rate was 58%. In patients with ejection fraction 0.1-0.2, 9 out of 13 survived.
Conclusions:
- Intra-aortic balloon pump (IABP) provides a significant survival advantage for high-risk patients after coronary artery surgery.
- IABP is effective in managing refractory cardiogenic shock and facilitating weaning from cardiopulmonary bypass.
- This temporary mechanical circulatory support can save lives in patients who might otherwise not survive complex cardiac procedures.
Abstract:
Intraaortic balloon pump (IABP) assist was employed in 36 patients after surgical operation for coronary artery disease. In 31 patients, the aid of IABP was required because cardiopulmonary bypass could not be terminated without it. In three of these patients, IABP assist was started before the surgical procedure because these patients were in cardiogenic shock due to myocardial infarction. In the remaining five patients, IABP assist was applied for refractory cardiogenic shock in the early postoperative period. The overall survival rate was 58 percent. IABP assist was used in 13 patients with an ejection fraction of 0.1 to 0.2 (normal 0.7). Nine of these patients survived. From our experience, it would appear that this temporary mechanical circulatory support provides a significant advantage in saving patients who might otherwise die after surgical procedures involving the coronary artery.